Donor Statin Treatment for Prevention of Severe Acute GVHD After Nonmyeloablative Hematopoietic Cell Transplantation
Phase of Trial: Phase II
Latest Information Update: 14 Feb 2018
At a glance
- Drugs Atorvastatin (Primary) ; Ciclosporin; Fludarabine; Mycophenolate mofetil
- Indications Graft-versus-host disease
- Focus Therapeutic Use
- 08 Feb 2018 Planned primary completion date changed from 26 May 2018 to 26 Oct 2018.
- 12 Sep 2017 Planned primary completion date changed from 1 May 2018 to 26 May 2018.
- 10 Jun 2017 Biomarkers information updated